Skip to main content
Equibles
MGNX logo

MGNX · Macrogenics Inc · Metrics

Track MGNX — free

Use MGNX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research MGNX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$4.00 +0.03 (+0.76%) At close · Sep 11
Russell 2000 member Rebalance outlook locked
Market Cap
$254.80M
Shares
63.70M

MGNX metrics

65 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$4.00
Market cap
$254.80M

Price action

20 metrics
Price change (1W)
-9.1%
Price change (30D)
-5.2%
Price change (3M)
+1.0%
Price change (6M)
+33.3%
Price change (YTD)
+148.4%
Price change (1Y)
+142.4%
Trailing year
Price change (5Y)
-84.1%
52-week high
$4.86
52-week low
$1.33
Change from 52-week high
-17.7%
Change from 52-week low
+200.8%
Annualized volatility
86.3%
Annualized volatility (3M)
62.9%
Beta
1.0
RSI (14D)
46.1
Price vs SMA 50
-3.6%
Price vs SMA 200
+30.0%
Avg volume (3M)
845,228
Relative volume
0.5
Average dollar volume
$3.68M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
63.70M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
1.4×
reciprocal yield 71.8%
P / book
5.9
reciprocal yield 16.8%
FCF yield
-25.7%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-5.7%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-05-20

Profitability

9 metrics
Gross margin
100.0%
Operating margin
-18.7%
Trailing 12 months
Net margin
-8.0%
Gross profit (TTM)
—
Operating profit (TTM)
−$34.28M
Net income (TTM)
−$14.59M
Trailing 12 months
Diluted EPS (TTM)
$-0.23
FCF margin
-35.8%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$0.88

Growth

11 metrics
Revenue growth YoY
+378.0%
Year over year
Net income growth YoY
—
Revenue (TTM)
$183.05M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+0.7%
Year over year · more shares
Revenue CAGR (3Y)
-0.5%
Revenue CAGR (5Y)
+7.3%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-34.0%
Return on assets
-4.2%
Debt / equity
—
Current ratio
3.0
EBITDA (TTM)
−$28.39M
Free cash flow (TTM)
−$65.54M
Quick ratio
—
Interest coverage
-2.0
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$113.91M
Latest balance sheet
Cash & equivalents
$113.91M
Total assets
$345.41M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$63.72M
Capital expenditures (TTM)
$1.82M
R&D (TTM)
$140.44M
SG&A (TTM)
—
Stock compensation (TTM)
$10.83M
R&D / revenue
76.7%
Stock compensation / revenue
5.9%

Ownership (13F)

3 metrics
13F filers
122
13F filer change QoQ
+13
Institutional ownership
76.6%

Short interest

3 metrics
Short interest
11.2%
Latest settlement · 17.3 days to cover
Days to cover
17.3d
Short-squeeze score
74 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$129,086
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1125345 CUSIP 556099109 13F (30d) 52 filings 52 filers Visit website Investor relations